INVO Fertility: Meeting Demand Amid China's Shift to Advanced Reproductive Technologies for Older Parents

China's Shift Towards Advanced Reproductive Technologies: A Response to Rising Maternal Age

At the recent 18th Annual Conference of the Chinese Society of Reproductive Medicine (CSRM2025), held from November 12-15, 2025, experts highlight a notable demographic shift in China’s reproductive landscape. The average age of women undergoing in vitro fertilization (IVF) has reached 33.6 years, indicating a significant trend toward older maternal age. This change not only reflects evolving societal norms surrounding family planning but also underscores the pressing need for advanced reproductive technologies to support older prospective parents. As women delay childbirth for various reasons, including career aspirations and personal circumstances, the demand for specialized reproductive assistance is on the rise.

One of the most pivotal advancements in this field is Preimplantation Genetic Testing (PGT). Data from 2021 reveal that PGT achieves a clinical pregnancy rate (CPR) of 60.2%, significantly surpassing the early CPRs of traditional IVF and Intracytoplasmic Sperm Injection (ICSI), which stand at 41.6% and 47.4%, respectively. PGT plays a critical role in reducing the risk of chromosomal abnormalities, thereby enhancing the likelihood of successful pregnancies. For older women, who face increased risks of infertility and genetic disorders, PGT offers a more reliable path to parenthood. This technological innovation not only boosts pregnancy success rates but also raises live birth delivery rates, making it an essential tool in the arsenal of reproductive medicine.

As the demand for advanced reproductive technologies continues to grow, companies like BaseCare Medical are stepping up to meet the needs of this changing demographic. BaseCare Medical recently launched an integrated system that combines several advanced technologies—namely "GERI + GEMS + AI"—aimed at optimizing IVF success rates. This system is designed to enhance the efficiency and effectiveness of assisted reproductive technologies, particularly for older women seeking fertility solutions. By adopting a proactive approach to the challenges posed by advanced maternal age, BaseCare Medical positions itself as a leader in addressing the evolving needs of prospective parents in China and potentially beyond.

The increasing reliance on advanced reproductive technologies like PGT and innovative systems from companies such as BaseCare Medical reflects broader societal changes in family planning and reproductive health. As more individuals prioritize their careers or personal lives before starting families, the landscape of reproductive medicine must adapt accordingly. This evolution not only enhances the possibilities for older parents but also highlights the critical role that technological advancements play in shaping the future of reproductive health.

As these developments unfold, it is clear that the reproductive health industry is entering a new era, one that is increasingly defined by technological solutions designed to accommodate the unique challenges faced by older prospective parents.